Molecular Imaging Sheds New Light On Progression Of Alzheimer's Disease
Wednesday, June 18, 2008 - 19:28
in Health & Medicine
In the past, physicians were able only to follow the progression of Alzheimer's disease through careful clinical histories, noting the often subtle changes associated with cognitive decline over a number of years. Recent research suggests that the use of molecular imaging in the management of neurodegenerative disease, particularly for early diagnosis of AD, will enable researchers to monitor the progression of the disease, identifying those at risk and assessing the effectiveness of new therapies.
Read the whole article on Science Daily
More from Science Daily
Related
- Molecular imaging sheds new light on progression of Alzheimer's diseaseMon, 16 Jun 2008, 18:07:41 EDT
- Pittsburgh Compound B finds Alzheimer’s-associated plaques in symptom-free older adultsMon, 10 Nov 2008, 17:43:37 EST
- Diabetes and elevated levels of cholesterol linked to faster cognitive decline in Alzheimer's patientsMon, 9 Mar 2009, 18:30:24 EDT
- Blood test shows promise for early diagnosis of Alzheimer's diseaseWed, 21 Oct 2009, 10:18:02 EDT
- Novel treatments and current clinical trials for Alzheimer's disease therapies show promiseThu, 23 Oct 2008, 12:09:09 EDT